RPCRC Validation Study

NCT04484103 · clinicaltrials.gov ↗

UNKNOWN

Status

275

Enrollment

OTHER

Sponsor class

Conditions

Multivariate Risk Assessment for ISUP ≥2 Prostate Cancer

Interventions

OTHER: Assessment of the diagnostic performance of the PI-RADS score (as a stand-alone) and of the RPCRC for predicting the presence of ISUP ≥2 prostate cancer at subsequent biopsy in 251 patients.

Sponsor

Hospices Civils de Lyon